nad has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danser, AH; de Vries, R; Saxena, PR; Schuijt, MP; Sluiter, W; Tom, B; van Kats, JP | 1 |
1 other study(ies) available for nad and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetophenones; Adolescent; Adult; Angiotensin II; Animals; Catecholamines; Child; Child, Preschool; Coronary Vessels; Cyclic N-Oxides; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Female; Femoral Artery; Free Radical Scavengers; Humans; Imidazolines; Male; Myocardial Contraction; NAD; NADP; Nitroprusside; Oxidants; S-Nitroso-N-Acetylpenicillamine; Spin Labels; Superoxide Dismutase; Superoxides; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Xanthine Oxidase | 2003 |